Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral midazolam solution vs dexmedetomidine nasal drops for pediatric preoperative sedation
ChiCTR2400089247Phase 4Not yet recruiting
- Sponsor
- Xi'an International Medical Center Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in separation anxiety disorder (SAD) comparing Oral midazolam solution group with Dexmedetomidine nasal drops group (2 arms). Primary endpoints: Separation Anxiety Score from Parents (PSAS) and Mask Induction Acceptance Score. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
midazolamdexmedetomidine
03
Conditions
separation anxiety disorder (SAD)
Beyond the preview
Go deeper on ChiCTR2400089247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089247.